Herbert J. Conrad, Director at Matinas BioPharma Holdings, Inc. (MTNB), bought 25,000 shares at $0.96 ($24K) on 2019-05-16, disclosed to the SEC on 2019-05-20.
Open-market purchase of $24k MTNB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| SVNT | SELL | 2008-05-06 | $239K | — | Filing → |
| SVNT | SELL | 2008-04-03 | $215K | — | Filing → |
| SVNT | SELL | 2008-03-05 | $229K | — | Filing → |